Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ORCL vs GSK✓SelectedUSD · GSKORCL vs GSK performance historyLatest closeAs of-4.99%11/16
Stock and ETF performance explorer

ORCL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+248.2%
GSK return
+107.3%
Excess return
+140.9%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.0%-0.1%-4.9%-5.0%
7D-0.6%-1.3%+0.7%-0.4%
30D-7.1%+2.7%-9.9%-7.8%
3M-20.6%+2.7%-23.3%-21.3%
6M-37.8%+3.3%-41.2%-38.8%
YTD-38.1%+6.5%-44.5%-40.2%
1Y-45.8%+10.7%-56.5%-48.3%
3Y+7.6%+64.4%-56.8%-12.9%
5Y+33.3%+46.7%-13.4%+10.9%
10Y+248.2%+109.4%+138.9%+152.3%
All+248.2%+107.3%+140.9%+152.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling